Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data.
作者信息
Brown Rebecca J, Rother Kristina I
机构信息
Clinical Endocrinology Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
出版信息
Pediatr Diabetes. 2008 Jun;9(3 Pt 2):14-22. doi: 10.1111/j.1399-5448.2007.00272.x. Epub 2008 Jan 24.
Abstract
摘要
相似文献
1
Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data.
Pediatr Diabetes. 2008 Jun;9(3 Pt 2):14-22. doi: 10.1111/j.1399-5448.2007.00272.x. Epub 2008 Jan 24.
2
C-peptide in the natural history of type 1 diabetes.
Diabetes Metab Res Rev. 2009 May;25(4):325-8. doi: 10.1002/dmrr.943.
3
Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.
Pediatr Diabetes. 2017 May;18(3):196-203. doi: 10.1111/pedi.12374. Epub 2016 Mar 6.
4
Immune therapy and β-cell death in type 1 diabetes.
Diabetes. 2013 May;62(5):1676-80. doi: 10.2337/db12-1207. Epub 2013 Feb 19.
5
[Evaluation of preserved insulin secretion in children and adolescents with type 1 diabetes].
Pediatr Endocrinol Diabetes Metab. 2010;16(2):67-71.
6
Characterization of residual β cell function in long-standing type 1 diabetes.
Diabetes Metab Res Rev. 2014 Feb;30(2):154-62. doi: 10.1002/dmrr.2478.
7
Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.
Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-13-S2-20. doi: 10.1089/dia.2013.0107.
8
Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Diabetes Care. 2009 Dec;32(12):2251-7. doi: 10.2337/dc09-0773. Epub 2009 Oct 6.
9
Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
Diabetes. 2017 Jun;66(6):1443-1452. doi: 10.2337/db16-1551.
10
Preservation of beta cell function.
Pediatr Diabetes. 2010 May;11(3):152-3. doi: 10.1111/j.1399-5448.2010.00675.x.
引用本文的文献
1
New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals.
Front Immunol. 2025 May 9;16:1522356. doi: 10.3389/fimmu.2025.1522356. eCollection 2025.
2
Role of EP4 factor in paediatric type 1 diabetes mellitus: a comprehensive review focusing on the honeymoon period.
Pediatr Endocrinol Diabetes Metab. 2024;30(4):227-246. doi: 10.5114/pedm.2024.146686.
3
Beta cell dedifferentiation in type 1 diabetes: sacrificing function for survival?
Front Endocrinol (Lausanne). 2024 Jun 6;15:1427723. doi: 10.3389/fendo.2024.1427723. eCollection 2024.
4
Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus.
Diabetes Metab J. 2024 Nov;48(6):1135-1146. doi: 10.4093/dmj.2023.0359. Epub 2024 Jun 17.
5
Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes.
Cell Metab. 2024 Jan 2;36(1):48-61.e6. doi: 10.1016/j.cmet.2023.11.011. Epub 2023 Dec 20.
6
Effect of Selenium Nanoparticles and/or Bee Venom against STZ-Induced Diabetic Cardiomyopathy and Nephropathy.
Metabolites. 2023 Mar 8;13(3):400. doi: 10.3390/metabo13030400.
7
Donor noradrenaline use is associated with better allograft survival in recipients of pancreas transplantation.
Ann R Coll Surg Engl. 2024 Jan;106(1):19-28. doi: 10.1308/rcsann.2022.0161. Epub 2023 Mar 16.
8
Therapeutic Strategies Targeting Pancreatic Islet β-Cell Proliferation, Regeneration, and Replacement.
Endocrinology. 2022 Nov 14;164(1). doi: 10.1210/endocr/bqac193.
9
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.
iScience. 2022 Jul 19;25(8):104771. doi: 10.1016/j.isci.2022.104771. eCollection 2022 Aug 19.
10
Beneficial metabolic effects of recurrent periods of beta-cell rest and stimulation using stable neuropeptide Y1 and glucagon-like peptide-1 receptor agonists.
Diabetes Obes Metab. 2022 Dec;24(12):2353-2363. doi: 10.1111/dom.14821. Epub 2022 Aug 11.
本文引用的文献
1
Diabetes treatment--bridging the divide.
N Engl J Med. 2007 Apr 12;356(15):1499-501. doi: 10.1056/NEJMp078030.
2
Hyperglycemia and hyperinsulinemia have additive effects on activation and proliferation of pancreatic stellate cells: possible explanation of islet-specific fibrosis in type 2 diabetes mellitus.
J Cell Biochem. 2007 Jun 1;101(3):665-75. doi: 10.1002/jcb.21222.
3
Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1.
J Biol Chem. 2007 Jan 5;282(1):287-93. doi: 10.1074/jbc.M606118200. Epub 2006 Nov 15.
4
TLR4 links innate immunity and fatty acid-induced insulin resistance.
J Clin Invest. 2006 Nov;116(11):3015-25. doi: 10.1172/JCI28898. Epub 2006 Oct 19.
5
Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes.
ILAR J. 2006;47(3):225-33. doi: 10.1093/ilar.47.3.225.
6
Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus.
Metabolism. 2006 May;55(5):691-5. doi: 10.1016/j.metabol.2006.01.003.
7
The biology of incretin hormones.
Cell Metab. 2006 Mar;3(3):153-65. doi: 10.1016/j.cmet.2006.01.004.
8
Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells.
Diabetes. 2005 Sep;54(9):2602-11. doi: 10.2337/diabetes.54.9.2602.
9
A comprehensive review of interventions in the NOD mouse and implications for translation.
Immunity. 2005 Aug;23(2):115-26. doi: 10.1016/j.immuni.2005.08.002.
10
Intensive insulin therapy protects the endothelium of critically ill patients.
J Clin Invest. 2005 Aug;115(8):2277-86. doi: 10.1172/JCI25385.
Zotero 插件